Prognostic and response markers in the management of breast cancer

Cancer Treatment Reviews

Volumn 23, Issue SUPPL. 1, 1997, Pages

  Robertson, John ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; KI 67 ANTIGEN; TUMOR MARKER;

BREAST CANCER; BREAST METASTASIS; CANCER RECURRENCE; CANCER SURVIVAL; CELL CYCLE S PHASE; HUMAN; LYMPH NODE METASTASIS; MULTIVARIATE ANALYSIS; ONCOGENE; PARTIAL MASTECTOMY; PROGNOSIS; REVIEW; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 0030666120     PISSN: 03057372     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-7372(97)90006-2     Document Type: Article

References (23)

1. Saez, S., Clark, G. M. & McGuire, W. L. (1988) Prognostic factors in cancer of the breast. Clin. Oncol. 2: 103-115.
2. Lewis, S., Locker, A., Todd, J. H., et al. (1990) Expression of epidermal growth factor receptor in breast carcinoma. Clin. Pathol. 43: 385-389.
3. Galea, M. H., Blamet, R. W., Elston, C. W. & Ellis, I. O.(1992) The Nottingham Prognostic Index in primary breast cancer. Br. Cancer Res. Treat. 22: 207-219.
4. Locker, A. P., Ellis, I. O., Morgan, D. A. L., Elston, C. W., Mitchell, A. & Blamey, R. W. (1989) Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br. J. Surg. 76: 890-894.
5. Sibbering, D. M., Galea, M. H., Morgan, D. A. L., et al. (1995) Safe selection criteria for breast conservation without radical excision in primary operable invasive breast cancer. Eur. J. Cancer 31A: 2192-2195.
6. O'Rourke, S., Galea, M. H., Morgan, D., et al. (1994) Local recurrence after simple mastectomy Br. J. Surg. 81: 386-389.
7. Archer, S. G., Sibbering, D. M., Morgan, D. A. L., et al. Regional recurrence following mastectomy for breast cancer (in preparation).
8. Williams, M. R., Todd, J. H., Nicholson, R. I., Elston, C. W., Blamey, R. W. & Griffiths, K. (1986) Survival patterns in hormone treated advanced breast cancer. Br. J. Surg. 73: 752-755.
9. Robertson, J. F. R. (1996) Oestrogen receptor: a stable phenotype in breast cancer. Br. J. Cancer 73: 5-12.
10. Coveney, E. C., Geraghty, J. G., Sherry, F., et al. (1995) The clinical value of CEA and CA15-3 in breast cancer management. Int. J. Biol. Mark. 10: 35-41.
11. Beatson, G. T. (1896) On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment, with illustrative cases reported the first case of endocrine therapy. Lancet ii: 104-107.
12. Lett, H. (1905) An analysis of 99 cases of inoperable carcinoma of the breast treated by oophorectomy. Lancet i: 227-228.
13. Nicholson, R. I., Bouzubar, N., Walker, K. J., et al. (1991) Hormone sensitivity in breast cancer: influence of heterogeneity of oestrogen receptor expression and cell proliferation. Eur. J. Cancer 27: 908-913.
14. Hilf, R., Feldstein, M. L., Savolv, E. T., et al. (1980) The relative importance of estrogen receptor analysis as a prognostic factor for recurrence or response to chemotherapy in women with breast cancer. Cancer 46: 1993-2000.
15. Mason, B. H., Holdaway, I. M., Mullins, P. R., et al. (1983) Progesterone and estrogen receptors as prognostic variables in breast cancer. Cancer Res. 43: 2985- 2990.
16. Howell, A., Barnes, D. M., Harland, R. N. L., et al. (1984) Steroid hormone receptors and survival after first relapse in breast cancer. Lancet i : 588-591.
17. Howat, J. M. T., Harris, H., Swindell, R., et al. (1985) The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast. Br. J. Cancer 51: 263-270.
18. Kinne, D. W., Butler, J. A., Kimmel, M., et al. (1987) Estrogen receptor protein of breast cancer in patients with positive nodes. Arch. Surg. 122: 1303-1306.
19. Robertson, J. F. R., Dixon, A. R., Nicholson, R. I., Ellis, I. O., Elston, S. W. & Blamey, R. W. (1992) Confirmation of a prognostic index for patients with metastatic breast cancer treated by endocrine therapy. Br. Cancer Res. Treat. 22: 221-227.
20. 2 expression and S-phase fraction in the prognosis of node positive breast cancer. Ann. Oncology 2: 47-53.
21. 2 oncoprotein expression in primary and advanced breast cancer. Br. J. Cancer 63: 439-443.
22. 2 protein overexpression in breast cancer is a risk factor in patients with involved and uninvolved lymph nodes. Br. J. Cancer 63: 434-438.
23. Winstanley, J., Cooke, T, Murray, G. D., et al. (1991) The long term prognostic significance of c-erbB-2 in primary breast cancer. Br. J. Cancer 63: 447-450.